Skip to main content
OpenTrials

Clinical trial condition

Bacterial Infections

Explore clinical trials studying Bacterial Infections. Study availability and eligibility vary by location and protocol.

4,521 public trials 497 recruiting studies
Refine in advanced search Browse all conditions

Bacterial Infections trial results

Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site Genoa, Liguria, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
  • GSK Investigational Site Novara, Piedmont, Italy
  • GSK Investigational Site Cagliari, Sardinia, Italy
View Trial Details
Completed

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

NCT00871338

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Ely, Cambridgeshire, United Kingdom
  • GSK Investigational Site Southampton, Hampshire, United Kingdom
  • GSK Investigational Site Oxford, Oxfordshire, United Kingdom
  • GSK Investigational Site Bristol, United Kingdom
View Trial Details
Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

NCT01738477

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Fullerton, California, United States
View all 20 locations
View Trial Details
Completed

Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

NCT00427908

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
View Trial Details
Completed

Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis

NCT01979900

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations
  • Jin Chengjiang Center for Diseases Control and Prevention, Hechi, Guangxi Hechi, Guangxi, China
  • Liucheng County Diseases Control and Prevention, Liuzhou, Guangxi Liuzhou, Guangxi, China
  • Liuzhou Center for Diseases Control and Prevention, Liuzhou, Guangxi Liuzhou, Guangxi, China
  • Rongshui County Diseases Control and Prevention, Liuzhou, Guangxi Liuzhou, Guangxi, China
View Trial Details

Related conditions